BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38707716)

  • 1. The Role of Speedy/RINGO Protein in Breast Cancer as a Future Biomarker.
    Tanriverdi O; Yildiz A
    Cancer Diagn Progn; 2024; 4(3):209-213. PubMed ID: 38707716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
    Gonzalez L; Nebreda AR
    Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of Cdk2-Speedy/Ringo A2.
    Cheng A; Gerry S; Kaldis P; Solomon MJ
    BMC Biochem; 2005 Sep; 6():19. PubMed ID: 16191191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins.
    Cheng A; Xiong W; Ferrell JE; Solomon MJ
    Cell Cycle; 2005 Jan; 4(1):155-65. PubMed ID: 15611625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of cell-cycle progression by RINGO/Speedy E.
    Dinarina A; Ruiz EJ; O'Loghlen A; Mouron S; Perez L; Nebreda AR
    Biochem J; 2008 Mar; 410(3):535-42. PubMed ID: 18072937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
    Dinarina A; Santamaria PG; Nebreda AR
    FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speedy/Ringo C regulates S and G2 phase progression in human cells.
    Cheng A; Solomon MJ
    Cell Cycle; 2008 Oct; 7(19):3037-47. PubMed ID: 18802405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speedy/RINGO regulation of CDKs in cell cycle, checkpoint activation and apoptosis.
    Gastwirt RF; McAndrew CW; Donoghue DJ
    Cell Cycle; 2007 May; 6(10):1188-93. PubMed ID: 17507798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a new family of cyclin-dependent kinase activators.
    Dinarina A; Perez LH; Davila A; Schwab M; Hunt T; Nebreda AR
    Biochem J; 2005 Mar; 386(Pt 2):349-55. PubMed ID: 15574121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins.
    Karaiskou A; Perez LH; Ferby I; Ozon R; Jessus C; Nebreda AR
    J Biol Chem; 2001 Sep; 276(38):36028-34. PubMed ID: 11461916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the Cdk-activator Speedy/RINGO in vertebrates.
    Chauhan S; Zheng X; Tan YY; Tay BH; Lim S; Venkatesh B; Kaldis P
    Cell Mol Life Sci; 2012 Nov; 69(22):3835-50. PubMed ID: 22763696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speedy/RINGO protein interacts with ERK/MAPK and PI3K/AKT pathways in SH-SY5Y neuroblastoma cells.
    Kaya Y; Kucukvardar S; Yildiz A
    Mol Cell Biochem; 2020 Oct; 473(1-2):133-141. PubMed ID: 32602013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDK activation by non-cyclin proteins.
    Nebreda AR
    Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylidene acylhydrazides attenuate survival of SH-SY5Y neuroblastoma cells through affecting mitotic regulator Speedy/RINGO and ERK/MAPK-PI3K/AKT signaling.
    Arziman S; Tanriverdi O; Kucukvardar S; Citil N; Yildiz A
    Med Oncol; 2020 Jul; 37(8):65. PubMed ID: 32691165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential phosphorylation of T-47D human breast cancer cell substrates by D1-, D3-, E-, and A-type cyclin-CDK complexes.
    Sarcevic B; Lilischkis R; Sutherland RL
    J Biol Chem; 1997 Dec; 272(52):33327-37. PubMed ID: 9407125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
    Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins.
    McGrath DA; Fifield BA; Marceau AH; Tripathi S; Porter LA; Rubin SM
    EMBO J; 2017 Aug; 36(15):2251-2262. PubMed ID: 28666995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation.
    Tu Z; Bayazit MB; Liu H; Zhang J; Busayavalasa K; Risal S; Shao J; Satyanarayana A; Coppola V; Tessarollo L; Singh M; Zheng C; Han C; Chen Z; Kaldis P; Gustafsson JÅ; Liu K
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):592-597. PubMed ID: 28031483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.